Enter your email below and we will send you a reset link.
Vyome Biosciences, an innovation-driven dermatology company, today announced that it has closed Series B financing of US$ 8 million led by Sabre Partners, with existing Series A investors Kalaari Capital and Aarin Capital also co-investing. The company focuses on developing novel and break through treatments for hard to treat and refractory skin conditions such as persistent […]
12 Aug 2014
Healthcare startups in the mid-western states of the US attracted about a quarter of all funding in this sector in the first half of 2014, according to the recently released BioEnterprise Midwest Healthcare Venture Investment Report. Midwest healthcare startups reported $777 million in total investments across 139 companies in the first half of 2014: the […]
08 Aug 2014